Tyra Biosciences, Inc.·4

Sep 8, 5:46 PM ET

Hudkins Robert L. 4

4 · Tyra Biosciences, Inc. · Filed Sep 8, 2022

Insider Transaction Report

Form 4
Period: 2022-09-06
Hudkins Robert L.
Chief Technology Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-09-06+105,000105,000 total
    Exercise: $7.14Exp: 2032-09-05Common Stock (105,000 underlying)
  • Award

    Common Stock

    2022-03-15$8.53/sh+2,408$20,529272,536 total
Footnotes (2)
  • [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
  • [F2]1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT